Related Experiment Video
Updated: Jun 22, 2026
08:54
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Antifungal carbazoles.
Karin Thevissen1, Arnaud Marchand, Patrick Chaltin
1CMPG, K.U. Leuven, Kasteelpark Arenberg 20, 3001 Heverlee, Belgium. karin.thevissen@biw.kuleuven.be
Current Medicinal Chemistry
|June 13, 2009
Summary
New N-alkylated 3,6-dihalogenocarbazoles show potent antifungal activity against Candida albicans and Candida glabrata. Some compounds also demonstrated efficacy against Candida biofilms, suggesting therapeutic potential as antimycotics.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Mycology
Background:
- Carbazole derivatives exhibit diverse pharmacological properties.
- Antifungal agents are crucial for combating human fungal pathogens like Candida albicans.
Purpose of the Study:
- To review carbazole derivatives with antifungal activity against Candida species.
- To identify novel antifungal compounds for potential therapeutic applications.
Main Methods:
- Literature review focusing on carbazoles with antifungal activity.
- Identification and characterization of N-alkylated 3,6-dihalogenocarbazoles.
- Determination of minimal fungicidal concentration (MFC) and activity against Candida biofilms.
Main Results:
- A series of N-alkylated 3,6-dihalogenocarbazoles demonstrated significant fungicidal activity against Candida albicans and Candida glabrata.
- The most potent compounds had minimal fungicidal concentrations between 8.5 and 25 microM.
- Several derivatives showed activity against Candida biofilms.
Conclusions:
- N-alkylated 3,6-dihalogenocarbazoles represent a promising class of antifungal compounds.
- These carbazole derivatives warrant further investigation for their therapeutic potential as antimycotics.
- Activity against biofilms highlights their potential for treating persistent Candida infections.
More Related Videos
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:29Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...